Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction

BACKGROUND: Dyslipidemia is common in heart failure with preserved ejection fraction. Sacubitril/valsartan improves glycemic control and augments natriuretic peptide signaling, providing mechanisms by which sacubitril/valsartan may affect serum lipids. However, empiric data on these effects are lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvaraj, Senthil, Claggett, Brian L., Packer, Milton, Zannad, Faiez, Anand, Inder S., Pieske, Burkert, Zhao, Ziqiang, Shi, Victor C., Lefkowitz, Martin P., McMurray, John J. V., Solomon, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649234/
https://www.ncbi.nlm.nih.gov/pubmed/33998278
http://dx.doi.org/10.1161/JAHA.121.022069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649234/
https://www.ncbi.nlm.nih.gov/pubmed/33998278
http://dx.doi.org/10.1161/JAHA.121.022069

Ejemplares similares